Zusammenfassung
Nanopartikuläre Substanzen finden in dermatologischen und kosmetischen Produkten zunehmend Anwendung, wobei die spezifischen Anforderungen an diese Nanosysteme dabei unterschiedlich ausfallen können. Als Bestandteil von Sonnenschutzmitteln sollen sich die Partikel beispielsweise hauptsächlich auf der Hautoberfläche und in den oberen Zelllagen des Stratum corneum anlagern, um die Haut optimal durch Reflexion und Absorption vor der UV-Strahlung der Sonne zu schützen. Als Trägersysteme für Wirkstoffe müssen die Partikel dagegen die Hautbarriere durchdringen, damit die Wirkstoffe die jeweiligen Zielstrukturen im Bereich der lebenden Zellen erreichen können. Im vorliegenden Beitrag werden die Perspektiven und Risiken der topischen Anwendung von Nanopartikeln diskutiert.
Abstract
Nanoparticles are experiencing an increasing application in dermatology and cosmetics. In both application areas, the requirements of nanoparticles are in most cases widely different. As a component of sunscreens, the nanoparticles are supposed to remain on the skin surface or in the upper most layers of the stratum corneum to protect the skin against UV-radiation of the sun. Whereas, on the other hand, when particulate substances are used as carrier systems for drugs, they have to cross the skin barrier to reach the target sites within the living tissue. We discuss the perspectives and risks of the topical application of nanoparticles.
Literatur
Nohynek GJ, Lademann J, Ribaud C et al (2007) Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 37:1–27
Bimczok R, Gers-Barlag H, Mundt C et al (2007) Influence of applied quantity of sunscreen products on the sun protection factor – a multicenter study organized by the DGK task force sun protection. Skin Pharmacol Physiol 20:57–64
Nohynek GJ, Dufour EK, Roberts MS (2008) Nanotechnology, cosmetics and the skin: is there a health risk? Skin Pharmacol Physiol 21:136–149
Lademann J, Rudolph A, Jacobi U et al (2004) Influence of nonhomogeneous distribution of topically applied UV filters on sun protection factors. J Biomed Opt 9:1358–1362
Weigmann HJ, Schanzer S, Herrling J et al (2006) Spectroscopic characterization of the sunscreen efficacy-basis of a universal sunscreen protection factor. SÖFW 9:2–10
Chatelain E, Gabard B, Surber C (2003) Skin penetration and sun protection factor of five UV filters: effect of the vehicle. Skin Pharmacol Appl Skin Physiol 16:28–35
Friends of the Earth (2006) Nanoparticles, sunscreens and cosmetics: Small ingredients, big risks. http://www foe org
Barry BW (2002) Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev 54 (Suppl 1):S31–S40
Ciotti SN, Weiner N (2002) Follicular liposomal delivery systems. J Liposome Res 12:143–148
du Plessis J, Ramachandran C, Weiner N et al (1994) The influence of particle size of liposomes on the deposition of drug into skin. Int J Pharm 103:277–282
Gehring W, Ghyczy M, Gloor M et al (1992) Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes. Arzneimittelforschung 42:983–985
Lademann J, Knorr F, Richter H et al (2008) Hair follicles – an efficient storage and penetration pathway for topically applied substances. Skin Pharmacol Physiol 21:150–155
Guglielmini G (2008) Nanostructured novel carrier for topical application. Clin Dermatol 26:341–346
Jung S, Otberg N, Thiede G et al (2006) Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol 126:1728–1732
Lademann J, Richter H, Schaefer UF et al (2006) Hair follicles – a long-term reservoir for drug delivery. Skin Pharmacol Physiol 19:232–236
Lademann J, Weigmann H, Rickmeyer C et al (1999) Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 12:247–256
Weigmann HJ, Ulrich J, Schanzer S et al (2005) Comparison of transepidermal water loss and spectroscopic absorbance to quantify changes of the stratum corneum after tape stripping. Skin Pharmacol Physiol 18:180–185
Weigmann HJ, Lademann J, Meffert H et al (1999) Determination of the horny layer profile by tape stripping in combination with optical spectroscopy in the visible range as a prerequisite to quantify percutaneous absorption. Skin Pharmacol Appl Skin Physiol 12:34–45
Otberg N, Richter H, Knuttel A et al (2004) Laser spectroscopic methods for the characterization of open and closed follicles. Laser Physics Letters 1:46–49
Langbein L, Grund C, Kuhn C et al (2002) Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. Eur J Cell Biol 81:419–435
Toshimori K, Yasuzumi F (1979) Tight junctions between ovarian follicle cells in the teleost (Plecoglossus altivelis). J Ultrastruct Res 67:73–78
Otberg N, Richter H, Schaefer H et al (2004) Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 122:14–19
Toll R, Jacobi U, Richter H et al (2004) Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 123:168–176
Lademann J, Richter H, Teichmann A et al (2007) Nanoparticles – an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 66:159–164
Patzelt A, Richter H, Buettemeyer R et al (2008) Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. Eur J Pharm Biopharm 70:234–238
Teichmann A, Jacobi U, Ossadnik M et al (2005) Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol 125:264–269
Vogt A, Combadiere B, Hadam S et al (2006) 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 126:1316–1322
Larese FF, D’Agostin F, Crosera M et al (2008) Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology (in press)
Shim J, Seok KH, Park WS et al (2004) Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J Control Release 97:477–484
Danksagung
Wir danken der Stiftung für Hautphysiologie beim Stifterverband für die Deutsche Wissenschaft, Essen, für die finanzielle Unterstützung.
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lademann, J., Meinke, M., Sterry, W. et al. Wie sicher sind Nanopartikel?. Hautarzt 60, 305–309 (2009). https://doi.org/10.1007/s00105-008-1627-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-008-1627-7